citiuspharma.comCitius Pharmaceuticals, Inc. - Unlocking Potential. Faster.

Overview Management Team Board of Directors Scientific Advisory Board Infectious Disease Partnering Pipeline LYMPHIR Mino-Lok® Stem Cell Platform Halo-Lido Clinical Trials & Publications Expanded Access Program Market Need CTCL CRBSI/CLABSI ARDS Hemorrhoids Investors Investment Highlights Press Releases & Media Press Releases Media Events & Presentations Events Corporate Presentation Stock Information Analyst Coverage Stock Quote Stock Chart Historical Stock Quote Investment Calculator Financials & SEC Filings Quarterly Results Annual Reports SEC Filings Governance Management Team Board of Directors Committee Composition Governance Documents Investor Resources Investor FAQs Information Request Form Investor Email Alerts Investor Contacts Contact We support Ukraine Unlocking Potential. Faster. Home About Overview Management Team Board of Directors Scientific Advisory Board Infectious Disease Partnering Pipeline LYMPHIR Mino-Lok® Stem Cell Platform Halo-Lido Clinical Trials & Publications Expanded Access Program Market Need CTCL CRBSI/CLABSI ARDS Hemorrhoids Investors Investment Highlights Press Releases & Media Press Releases Media Events & Presentations Events Corporate Presentation Stock Information Analyst Coverage Stock Quote Stock Chart Historical Stock Quote Investment Calculator Financials & SEC Filings Quarterly Results Annual Reports SEC Filings Governance Management Team Board of Directors Committee Composition Governance Documents Investor Resources Investor FAQs Information Request Form Investor Email Alerts Investor Contacts Contact Corporate Overview The Citius family stands in solidarity with the people of Ukraine and condemns the Russian assault on an independent democratic nation. The founders of Citius, as well as several members of its Board of Directors and management team, are of Ukrainian descent, with enduring ties to the Ukrainian community. As the tragic events in Ukraine unfold, the humanitarian crisis grows exponentially. We are reminded that progress, including scientific discovery, is made possible by the ability of free people, living in peace, to exercise the values and rights inherent in democratic societies. As such, we support the Ukrainian people in their effort to remain a sovereign and democratic nation. We encourage the entire Citius community to join us in supporting the many individuals and organizations answering the call to provide humanitarian aid to Ukraine. Organizations supporting relief efforts in Ukraine Razom Revived Soldiers Ukraine Ukrainian National Women’s League of America Ukrainian Congress Committee of America United Ukrainian American Relief Committee Voices of Children American Red Cross Catholic Relief Services Metrowest Federation United Jewish Appeal Campaign Ukraine Emergency Fund Unicef World Central Kitchen World Union for Progressive Judaism Ukraine Crisis Relief Fund YMCA Leonard Mazur, Chairman & CEO Myron Holubiak, Executive Vice Chairman Dr. Myron Czuczman, Chief Medical OfficerCitius Pharmaceuticals, Inc. (Nasdaq: CTXR) is a late-stage biopharmaceutical company focused on the development and commercialization of first-in-class critical care products, with a pipeline of anti-infectives in oncology, adjunct cancer care, stem cell therapy and unique prescription products. Read more Why Invest 4 Diversified Pipeline Candidates $ 26.5 M Invested by Founders $ 1.8 B Worldwide Sales Potential of Mino-Lok ® 2024 Inflection Point for Value Driving Catalysts Learn more Latest News View all news Latest Presentation Latest Events View All Events Latest Financial Reports View All Financial Reports Contact Us Citius Pharmaceuticals, Inc. 11 Commerce Drive, First Floor Cranford, NJ 07016 908-967-6677 [email protected] follow us on twitter follow us on linkedin Quick Links SEC Filings Investor FAQs Information Request Form Investor Email Alerts To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time. At Citius Pharmaceuticals, Inc. we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance. By providing your email address below, you are providing consent to Citius Pharmaceuticals, Inc. to send you the requested Investor Email Alert updates. * Required Email Address * Investor Alert Options Investor Alert Options * News Quarterly Reports Annual Reports SEC Filings Unsubscribe Email Alert Sign Up Confirmation REQUEST A MEETING WITH MANAGEMENT Disclaimer Terms of Use © Citius Pharmaceuticals, Inc. - All rights...